| Financial Year |
March 31 2023 |
| Monetary Funds |
1,424,987,846.11 |
| Held-for-trading Financial Assets |
147,297,136.30 |
| Notes Receivable |
6,910,506.20 |
| Accounts Receivable |
488,710,949.05 |
| Advances to Suppliers |
109,041,465.94 |
| Other Receivables |
16,478,740.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
998,582,559.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,472,063.50 |
| Total Current Assets |
3,348,261,049.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,000,587.01 |
| Long-term Equity Investment |
3,729,920.62 |
| Investment Properties |
20,561,309.29 |
| Fixed Assetes |
753,935,283.22 |
| Under-construction Projects |
91,869,811.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
195,151,889.32 |
| R&D expenses |
-- |
| Goodwill |
26,053,448.60 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
37,242,495.18 |
| Other Non-Current Assets |
2,417,604.88 |
| Sub-Total of Non-Current Assets |
1,368,065,030.18 |
| Total Assets |
4,716,326,079.50 |
| Short-Term Loans |
37,037,209.73 |
| Trading Financial liabilities |
-- |
| Notes Payable |
189,163,230.52 |
| Accounts Payable |
276,429,162.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,953,033.62 |
| Taxes Payable |
139,300,750.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,497,733.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
467,607.63 |
| Other Current Liabilities |
43,133,883.33 |
| Sub-Total of Current Liabilities |
1,712,334,016.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
30,799,208.90 |
| Deferred Income Tax Liabilities |
15,741,225.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
117,016,994.86 |
| Total Liabilities |
1,829,351,011.25 |
| Paid-In Capital(Or Share Stock) |
335,097,673.00 |
| Capital Surplus |
855,664,257.14 |
| Surplus Reserve |
128,009,656.44 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,553,020,410.22 |
| Minority Stockholder's Interest |
15,724,814.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,871,250,253.80 |
| Owner's Equity（Stockholder's Equity） |
2,886,975,068.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,716,326,079.50 |
